NovoRapid Administration and Dosing Guidelines
NovoRapid (insulin aspart) should be administered subcutaneously with initial prandial dosing starting at 4 units per meal or 10% of basal insulin dose, titrated by 1-2 units or 10-15% based on blood glucose response, with injections given 0-15 minutes before meals. 1
Administration Technique
Injection Sites and Rotation
- Preferred sites: Abdomen (fastest absorption), upper arms, anterior/lateral thighs, buttocks 2
- Avoid: 2-inch radius around the navel 2
- Rotation strategy: Rotate systematically within one area (e.g., different spots in abdomen) rather than switching between different body regions with each injection to minimize day-to-day absorption variability 2
Injection Technique
- Use 90° angle for most patients 2
- Thin individuals or children: Consider 45° angle with skin pinch to avoid intramuscular injection 2
- Keep needle embedded in skin for 5 seconds after complete delivery 2
- No need for routine aspiration 2
Dosing Algorithm
Initial Prandial Insulin Dosing
When adding NovoRapid to existing therapy 1:
- Start with: 4 units with largest meal OR 10% of basal insulin dose
- Alternative: If converting from bedtime NPH, use 10% of reduced NPH dose
Titration Strategy
Increase dose when A1C above goal 1:
- Increase by 1-2 units per injection OR
- Increase by 10-15% of current dose
Decrease dose for hypoglycemia 1:
- If clear cause identified: Address the cause
- If no clear reason: Lower dose by 10-20%
Timing Relative to Meals
- Optimal timing: 15-30 minutes before meals 3
- NovoRapid has faster onset than regular insulin (peak action at 51-60 minutes vs 105-109 minutes) 4
- Timing depends on blood glucose levels, food consumption, and exercise 2
Blood Glucose-Based Dosing Considerations
General Principles
The appropriate insulin dosage depends on individual glycemic response to food intake and exercise 2. While guidelines don't provide rigid glucose-level-to-unit conversion tables, the following framework applies:
- Dosing must be individualized based on continuous blood glucose monitoring results 2
- Consider insulin-to-carbohydrate ratios and correction factors developed with your physician
- Variables affecting insulin action (onset, peak, duration) must be considered 2
Clinical Context for Dose Adjustment
- If A1C <8%: Consider lowering basal dose by 4 units/day or 10% when adding prandial insulin 1
- Monitor preprandial and postprandial glucose differentials to assess adequacy 1
- Watch for signs of overbasalization: elevated bedtime-to-morning differentials, hypoglycemia, high glucose variability 1
Critical Safety Considerations
Hypoglycemia Prevention
Common causes to avoid 2:
- Excess insulin dosing
- Delayed or missed meals
- Decreased carbohydrate content
- Increased physical activity
- Increased absorption rates (hot water exposure, sunbathing, exercise)
Safety measures:
- Carry at least 15g carbohydrate at all times 2
- Family members should know glucagon administration for type 1 diabetes 2
- Carry medical identification 2
Absorption Variability Factors
- Fastest absorption: Abdomen 2
- Slower absorption: Arms, then thighs, then buttocks 2
- Exercise increases absorption at injection sites 2
- Lipohypertrophy areas show slower absorption 2
Monitoring Requirements
- Self-monitoring of blood glucose is essential for all insulin users 2
- Insulin dosage adjustments should be based on blood glucose measurements 2
- Assess insulin dose adequacy at every visit 1
Common Pitfalls to Avoid
- Don't rotate between different body areas with each injection—this increases absorption variability 2
- Don't use intramuscular injection for routine administration (faster, unpredictable absorption) 2
- Don't ignore lipohypertrophy sites—they significantly slow absorption 2
- Don't delay titration—increase by 1-2 units when A1C remains above goal 1